VIRGINIA RETIREMENT SYSTEMS ET Al Takes $28.16 Million Position in Humana Inc. $HUM

VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Humana Inc. (NYSE:HUM) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 115,200 shares of the insurance provider’s stock, valued at approximately $28,164,000. VIRGINIA RETIREMENT SYSTEMS ET Al owned approximately 0.10% of Humana as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Cary Street Partners Investment Advisory LLC lifted its position in shares of Humana by 63.9% in the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock valued at $31,000 after acquiring an additional 46 shares in the last quarter. Applied Finance Capital Management LLC lifted its position in shares of Humana by 1.7% in the first quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider’s stock valued at $779,000 after acquiring an additional 48 shares in the last quarter. Blue Trust Inc. lifted its position in shares of Humana by 3.6% in the second quarter. Blue Trust Inc. now owns 1,367 shares of the insurance provider’s stock valued at $334,000 after acquiring an additional 48 shares in the last quarter. Achmea Investment Management B.V. lifted its position in shares of Humana by 0.5% in the first quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider’s stock valued at $2,746,000 after acquiring an additional 49 shares in the last quarter. Finally, Beech Hill Advisors Inc. lifted its position in shares of Humana by 6.1% in the first quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider’s stock valued at $229,000 after acquiring an additional 50 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Stock Performance

Shares of NYSE:HUM opened at $275.00 on Monday. The firm has a market capitalization of $33.07 billion, a PE ratio of 21.11, a P/E/G ratio of 1.61 and a beta of 0.42. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. The business has a 50-day moving average of $280.54 and a two-hundred day moving average of $258.14. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $315.35.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The company had revenue of $32.39 billion during the quarter, compared to analyst estimates of $31.85 billion. During the same quarter last year, the business posted $6.96 EPS. Humana’s quarterly revenue was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.885 dividend. The ex-dividend date is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.3%. Humana’s dividend payout ratio (DPR) is 27.17%.

Analyst Ratings Changes

HUM has been the subject of several analyst reports. Bank of America upped their target price on Humana from $280.00 to $300.00 and gave the company a “neutral” rating in a research note on Friday, October 10th. Wells Fargo & Company upped their target price on Humana from $344.00 to $347.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Piper Sandler dropped their target price on Humana from $288.00 to $272.00 and set a “neutral” rating for the company in a research note on Thursday, July 31st. Barclays dropped their target price on Humana from $315.00 to $245.00 and set an “equal weight” rating for the company in a research note on Friday, October 3rd. Finally, Truist Financial set a $300.00 target price on Humana in a research note on Tuesday, October 14th. Eight analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $297.58.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.